Operose Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,193
Closed -$16.1K – 689
2026
Q1
$16.1K Buy
+1,193
New +$16.7K ﹤0.01% 376
2025
Q2
– Sell
-33
Closed -$287 – 422
2025
Q1
$287 Hold
33
– – ﹤0.01% 379
2024
Q4
$411 Hold
33
– – ﹤0.01% 417
2024
Q3
$383 Hold
33
– – ﹤0.01% 608
2024
Q2
$351 Hold
33
– – ﹤0.01% 576
2024
Q1
$394 Hold
33
– – ﹤0.01% 640
2023
Q4
$357 Hold
33
– – ﹤0.01% 590
2023
Q3
$325 Hold
33
– – ﹤0.01% 746
2023
Q2
$329 Hold
33
– – ﹤0.01% 350
2023
Q1
$317 Hold
33
– – ﹤0.01% 339
2022
Q4
$367 Hold
33
– – ﹤0.01% 353
2022
Q3
$1K Hold
33
– – ﹤0.01% 337
2022
Q2
$1K Hold
33
– – ﹤0.01% 298
2022
Q1
$1K Hold
33
– – ﹤0.01% 315
2021
Q4
$0 Buy
+33
New +$441 ﹤0.01% 301

Other funds holding VTRS

Operose Advisors's VTRS Position: Q2 2026 in Review

Operose Advisors sold out of Viatris (VTRS) in Q2 2026, closing a stake of 1,193 shares — an estimated $16.1K sold.

Operose Advisors first reported a position in VTRS in Q4 2021 and held it in 15 quarters. The position peaked at $16.1K in Q1 2026. 1,033 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Operose Advisors reported no remaining Viatris position as of Q2 2026 after selling out during the quarter.
  • Operose Advisors sold 1,193 Viatris shares in Q2 2026, an estimated $16.1K.
  • Operose Advisors first reported a position in Viatris in Q4 2021 and held it in 15 quarters.
  • Operose Advisors's Viatris position peaked at $16.1K in Q1 2026.
  • 1,033 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Operose Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.